» Articles » PMID: 9661995

Autoantibodies in Neurodegenerative Diseases: Antigen-specific Frequencies and Intrathecal Analysis

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 1998 Jul 14
PMID 9661995
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The frequency of autoantibodies (AAbs) was surveyed in several neurodegenerative diseases, other neurological diseases, and controls using antigen-specific EIAs for neurofilament heavy subunit, tubulin, glial fibrillary acidic protein, S100 protein, tau, beta-amyloid peptide, myelin basic protein, and heparan sulfate proteoglycan. High frequencies of sera and cerebrospinal fluid tubulin AAbs were found in Alzheimer disease (62% and 69%, respectively), Parkinson disease (27% and 70%), amyotrophic lateral sclerosis (54% and 67%), and in sera from multiple sclerosis (50% and 67%), optic neuritis (85%), Guillain-Barré syndrome (88%), and vascular dementia (52%). High frequencies of neurofilament heavy subunit AAbs were detected in Guillain-Barré syndrome, chronic peripheral neuropathy (88%) and optic neuritis (62%); whereas, some Alzheimer's disease (33%) and vascular dementia (44%) patients had glial fibrillary acidic protein AAbs. Lower frequencies of other AAbs were found in patient groups. AAb results were also compared to functional assessment of blood-brain barrier integrity in Parkinson's disease and Alzheimer's disease. The relevance of these AAbs to pathogenesis and/or course of neurologic diseases merits further study with particular reference to subgrouping and prognosis.

Citing Articles

Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.

Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Hamad H, Chandran M Front Neurol. 2023; 14:1256745.

PMID: 38107644 PMC: 10722091. DOI: 10.3389/fneur.2023.1256745.


The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans.

Pandey M Front Aging Neurosci. 2022; 14:902191.

PMID: 35721016 PMC: 9204601. DOI: 10.3389/fnagi.2022.902191.


Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.

Kocurova G, Ricny J, Ovsepian S Theranostics. 2022; 12(7):3045-3056.

PMID: 35547759 PMC: 9065204. DOI: 10.7150/thno.72126.


Biomarker of Neuroinflammation in Parkinson's Disease.

Liu T, Chen C, Chang K Int J Mol Sci. 2022; 23(8).

PMID: 35456966 PMC: 9028544. DOI: 10.3390/ijms23084148.


Serum and Saliva Myelin Basic Protein as Multiple Sclerosis Biomarker.

Mirzaii-Dizgah M, Mirzaii-Dizgah M, Mirzaii-Dizgah I Basic Clin Neurosci. 2021; 12(3):309-314.

PMID: 34917290 PMC: 8666920. DOI: 10.32598/bcn.2021.950.2.